Sign In
Buy ALT
$2.92
+0.0500 (+1.74%)
At Close: Jun 04, 2026
Investors who lost money on Altimmune, Inc.(ALT) should contact Levi & Korsinsky about pending Class Action - ALT
05:30am, Thursday, 04'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
FINAL ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class Action Lawsuit!
05:00am, Thursday, 04'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Altimmune, Inc. (
FINAL ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class Action Lawsuit
05:00am, Thursday, 04'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Altimmune, Inc. (
Shareholders that lost money on Altimmune, Inc.(ALT) should contact Levi & Korsinsky about pending Class Action - ALT
10:40pm, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds those who purchased common stock or purchased call options or sold put options, including an
Levi & Korsinsky Notifies Altimmune, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ALT
09:15pm, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
Shareholders that lost money on Altimmune, Inc. (ALT) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
09:15pm, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc.(ALT) Shareholders
10:15am, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
09:55am, Wednesday, 03'rd Jul 2024
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Altimmune To Contact Him Directly To Discuss Their Options If you s
Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
07:00am, Wednesday, 03'rd Jul 2024
Clinical-state biopharmaceutical company Altimmune Inc. NASDAQ: ALT focuses on developing peptide-based therapeutics for obesity and chronic liver diseases, including non-alcoholic steatohepatitis (NA
Altimmune, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT
05:30am, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
Contact Levi & Korsinsky by July 5, 2024 Deadline to Join Class Action Against Altimmune, Inc.(ALT)
05:13am, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
IMMINENT ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class Action Lawsuit!
05:00am, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Altimmune, Inc. (
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
July 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALT
11:15pm, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
